Nkarta Inc. (NKTX)
NKTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.10
-3.23% on the day
Market cap
$150.4M
Micro cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$104.1M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NKTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001787400 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$104.1M |
| Operating income | -$122.0M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $39.6M |
| Total assets | $404.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-03 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-08-10 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 436 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MSLE | Satellos Bioscience Inc. | $7.04 | -1.81% | $149.4M |
| NBP | NovaBridge Biosciences | $1.29 | -2.27% | $148.8M |
| MENS | Jyong Biotech Ltd. | $2.04 | -2.86% | $155.1M |
| ORGO | Organogenesis Holdings Inc. | $1.21 | -1.63% | $155.7M |
| CUE | Cue Biopharma Inc. | $19.57 | -20.48% | $142.2M |
| DERM | Journey Medical Corporation | $5.68 | -3.89% | $160.3M |
| CNTN | Canton Strategic Holdings Inc. | $2.02 | -4.26% | $161.0M |
| BGM | BGM Group Ltd. | $10.48 | +2.75% | $140.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier